2020CPIC 指南： CYP2C19 和质子泵抑制剂给药剂量

2022-06-01 清华大学第一附属医院药学部清华大学第一附属医院药学部

质子泵抑制剂(PPIs)广泛用于治疗和预防胃食管反流病(GERD)、胃和十二指肠溃疡、糜烂性食管炎、嗜酸细胞性食管炎、幽门螺杆菌(Hp)感染以及成人和儿童的病理性高分泌状态。大多数 PPI

中文标题：

发布机构：

清华大学第一附属医院药学部

发布日期：

2022-06-01

简要介绍：

质子泵抑制剂(PPIs)广泛用于治疗和预防胃食管反流病(GERD)、胃和十二指肠溃疡、糜烂性食管炎、嗜酸细胞性食管炎、幽门螺杆菌(Hp)感染以及成人和儿童的病理性高分泌状态。大多数 PPIs 主要经肝细胞色素 P4502C19(CYP2C19)酶广泛代谢为非活性物， CYP2C19 基因型与 PPI 暴露有关，低暴露量导致治疗失败，高暴露量有助于提高疗效。较高的 PPIs 暴露也与不良反应有关，也和 PPI 长期使用相关。本指南的目的是为临床医生提供信息，便于对 CYP2C19 基因检测结果进行解读，从而指导 PPI 类药物的开具。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=4176d1c002a68587, title=2020CPIC 指南： CYP2C19 和质子泵抑制剂给药剂量, enTitle=, guiderFrom=清华大学第一附属医院药学部, authorId=0, author=, summary=质子泵抑制剂(PPIs)广泛用于治疗和预防胃食管反流病(GERD)、胃和十二指肠溃疡、糜烂性食管炎、嗜酸细胞性食管炎、幽门螺杆菌(Hp)感染以及成人和儿童的病理性高分泌状态。大多数 PPI, cover=https://img.medsci.cn/20220614/1655220318490_5579292.png, journalId=0, articlesId=null, associationId=2843, associationName=清华大学第一附属医院药学部, associationIntro=清华大学第一附属医院药学部, copyright=0, guiderPublishedTime=Wed Jun 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=质子泵抑制剂(PPIs)广泛用于治疗和预防胃食管反流病(GERD)、胃和十二指肠溃疡、糜烂性食管炎、嗜酸细胞性食管炎、幽门螺杆菌(Hp)感染以及成人和儿童的病理性高分泌状态。大多数 PPIs 主要经肝细胞色素 P4502C19(CYP2C19)酶广泛代谢为非活性物， CYP2C19 基因型与 PPI 暴露有关，低暴露量导致治疗失败，高暴露量有助于提高疗效。较高的 PPIs 暴露也与不良反应有关，也和 PPI 长期使用相关。本指南的目的是为临床医生提供信息，便于对 CYP2C19 基因检测结果进行解读，从而指导 PPI 类药物的开具。, tagList=[TagDto(tagId=1835, tagName=质子泵抑制剂)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4664, appHits=102, showAppHits=0, pcHits=522, showPcHits=4562, likes=0, shares=33, comments=3, approvalStatus=1, publishedTime=Wed Jun 15 15:23:00 CST 2022, publishedTimeString=2022-06-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Jun 14 23:24:15 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 10:37:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020CPIC 指南： CYP2C19 和质子泵抑制剂给药剂量 (1).pdf)])

2020CPIC 指南： CYP2C19 和质子泵抑制剂给药剂量 (1).pdf

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1227479, encodeId=b729122e479ba, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Jun 20 07:37:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227301, encodeId=9bd6122e301ab, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sun Jun 19 08:18:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227262, encodeId=7d5f122e2622c, content=〈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c758201863, createdName=ms4000000099863083, createdTime=Sat Jun 18 21:36:33 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
2022-06-20 ms3000000376140643

学习学习

48 0
[GetPortalCommentsPageByObjectIdResponse(id=1227479, encodeId=b729122e479ba, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Jun 20 07:37:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227301, encodeId=9bd6122e301ab, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sun Jun 19 08:18:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227262, encodeId=7d5f122e2622c, content=〈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c758201863, createdName=ms4000000099863083, createdTime=Sat Jun 18 21:36:33 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
2022-06-19 ms3000000376140643

学习学习

51 0
[GetPortalCommentsPageByObjectIdResponse(id=1227479, encodeId=b729122e479ba, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Jun 20 07:37:55 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227301, encodeId=9bd6122e301ab, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Sun Jun 19 08:18:51 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227262, encodeId=7d5f122e2622c, content=〈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c758201863, createdName=ms4000000099863083, createdTime=Sat Jun 18 21:36:33 CST 2022, time=2022-06-18, status=1, ipAttribution=)]
2022-06-18 ms4000000099863083

〈

46 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化指南

2020CPIC 指南： CYP2C19 和质子泵抑制剂给药剂量

相关指南

科室

工具

服务